Safety Study of F2695 SR in Major Depressive Disorder

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the long- term safety of F2695-SR in the treatment of adults with major depressive disorder.

Phase 3

Forest Laboratories